Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Liver‐Specific Deletion of Mouse Tm6sf2 Promotes Steatosis, Fibrosis, and Hepatocellular Cancer
Elizabeth P. Newberry, Zoe Hall, Yan Xie, et al.
Hepatology (2021) Vol. 74, Iss. 3, pp. 1203-1219
Open Access | Times Cited: 90

Showing 26-50 of 90 citing articles:

Early-life antibiotic exposure aggravate the metabolic dysfunction-associated steatotic liver disease associated hepatocellular carcinoma
Panpan Tian, Xinyu Tian, Lifen Gao, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Advances in genetic variation in metabolism-related fatty liver disease
Fan Shi, Mei Zhao, Shudan Zheng, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 11
Unraveling the pathogenesis of non‐alcoholic fatty liver diseases through genome‐wide association studies
Ye Tian, Bo Wang
Journal of Gastroenterology and Hepatology (2023) Vol. 38, Iss. 11, pp. 1877-1885
Open Access | Times Cited: 10
Trojan Horse‐Like Biohybrid Nanozyme for Ameliorating Liver Ischemia‐Reperfusion Injury
Daofeng Zheng, Xiang‐Jun Zha, Enlai Jiang, et al.
Advanced Healthcare Materials (2025)
Closed Access
Unraveling Mechanisms of Genetic Risks in Metabolic Dysfunction–Associated Steatotic Liver Diseases: A Pathway to Precision Medicine
Xiang Zhang, Kyong‐Mi Chang, Jun Yu, et al.
Annual Review of Pathology Mechanisms of Disease (2025) Vol. 20, Iss. 1, pp. 375-403
Closed Access
Role of Microsomal Triglyceride Transfer Protein (MTP) in Lipid Processing Pathways in Retinal Pigment Epithelium
Catharina R. Grubaugh, Anuradha Dhingra, Aleena Defreitas, et al.
Advances in experimental medicine and biology (2025), pp. 363-367
Closed Access
Molecular Mechanisms by Which Polyunsaturated Fatty Acids Suppress the Pathogenesis and Progression of NAFLD
Miki Ando, Hyeon‐Cheol Lee, Takehiko Yokomizo
YAKUGAKU ZASSHI (2025) Vol. 145, Iss. 3, pp. 177-182
Open Access
Deciphering the shared genetic architecture between bipolar disorder and body mass index
Haochuan Ma, Yong‐Bin Wang, Yang Yang, et al.
Journal of Affective Disorders (2025)
Closed Access
The intracellular chylomicron highway: novel insights into chylomicron biosynthesis, trafficking, and secretion
Ankia Visser, M. Mahmood Hussain, Jan Albert Kuivenhoven
Current Opinion in Lipidology (2025)
Closed Access
New insights on mesenchymal stem cells therapy from the perspective of the pathogenesis of nonalcoholic fatty liver disease
Yanxuan Wen, Jiaxing Li, Omar Mukama, et al.
Digestive and Liver Disease (2025)
Closed Access
Evaluation of the efficacy of mitochondrial fission inhibitor (Mdivi-1) using non-alcoholic steatohepatitis (NASH) liver organoids
Mohamed Elbadawy, Kiwamu Tanabe, Haru Yamamoto, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 9
Dysfunctional VLDL metabolism in MASLD
Urko M. Marigorta, Óscar Millet, Shelly C. Lu, et al.
npj Metabolic Health and Disease (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 3
TM6SF2 E167K variant decreases PNPLA3-mediated PUFA transfer to promote hepatic steatosis and injury in MASLD
Baokai Sun, Xiaoqian Ding, Jie Tan, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 4, pp. 863-882
Open Access | Times Cited: 3
Human-induced pluripotent stem cell–based hepatic modeling of lipid metabolism–associated TM6SF2-E167K variant
Lanuza A. P. Faccioli, Yiyue Sun, Olamide Animasahun, et al.
Hepatology (2024)
Open Access | Times Cited: 3
Genetic variants associated with metabolic dysfunction‐associated fatty liver disease in western China
Shenling Liao, An Kang, Zhi Liu, et al.
Journal of Clinical Laboratory Analysis (2022) Vol. 36, Iss. 9
Open Access | Times Cited: 14
Non-coding RNAs regulating epithelial-mesenchymal transition: Research progress in liver disease
Yang Xiang, Zhitao Jiang, Yang Li, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 150, pp. 112972-112972
Open Access | Times Cited: 13
Nonalcohol fatty liver disease: balancing supply and utilization of triglycerides
Leinys S. Santos‐Báez, Henry N. Ginsberg
Current Opinion in Lipidology (2021) Vol. 32, Iss. 3, pp. 200-206
Open Access | Times Cited: 17
Lipid Droplet-Associated Factors, PNPLA3, TM6SF2, and HSD17B Proteins in Hepatopancreatobiliary Cancer
Yoshiaki Sunami, Artur Rebelo, Jörg Kleeff
Cancers (2021) Vol. 13, Iss. 17, pp. 4391-4391
Open Access | Times Cited: 16
Targeting T Cell Subtypes for NAFLD and NAFLD-Related HCC Treatment: An Opinion
Chunye Zhang, Ming Yang
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 16
Targeted activation ofHNF4α/HGF1/FOXA2reverses hepatic fibrosis via exosome-mediated delivery of CRISPR/dCas9-SAM system
Nianan Luo, Wenjun Zhong, Jiangbin Li, et al.
Nanomedicine (2022) Vol. 17, Iss. 20, pp. 1411-1427
Closed Access | Times Cited: 11
Impaired Hepatic Very Low-Density Lipoprotein Secretion Promotes Tumorigenesis and Is Accelerated with Fabp1 Deletion
Elizabeth P. Newberry, Elizabeth A. Molitor, Allen Liu, et al.
American Journal Of Pathology (2024) Vol. 194, Iss. 6, pp. 958-974
Closed Access | Times Cited: 2
Ablation of Hepatic Asah1 Gene Disrupts Hepatic Lipid Homeostasis and Promotes Fibrotic Non-Alcoholic Steatohepatitis in Mice
Rui Zuo, Mi Wang, Yunting Wang, et al.
American Journal Of Pathology (2024)
Open Access | Times Cited: 2
Nrf2 activation contributes to hepatic tumor-augmenting effects of developmental arsenic exposure
Ruirui Wu, Xin Chen, Hengchao Wu, et al.
The Science of The Total Environment (2022) Vol. 837, pp. 155685-155685
Closed Access | Times Cited: 9
New insights into the inter-organ crosstalk mediated by ChREBP
Thaïs Carbinatti, Marion Régnier, Lucia Parlati, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 4
Molecular mechanisms of liver carcinogenesis related to metabolic syndrome
Claudia Campani, Jean–Charles Nault
Hepatoma Research (2022)
Open Access | Times Cited: 7

Scroll to top